Welch Allyn vision screener display may flicker inducing photosensitive seizures
Baxter is recalling the Welch Allyn Spot Vision Screener VS100 on software version 3.2.0.1 because the display screen may unintentionally flicker, which may induce photosensitive seizure activity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: the source states flickering may induce seizure activity in susceptible individuals, and no injuries are stated.
Plain-English summary
Baxter Healthcare Corporation is recalling the Welch Allyn Spot Vision Screener VS100, an ophthalmic refractometer, running software version 3.2.0.1. About 59 units were distributed across 14 US states and to Colombia and India. The FDA has classified this recall as Class II.
The display screen may unintentionally flicker due to a software issue. Exposure to flickering lights may induce photosensitive seizure activity in susceptible individuals.
Affected product carries primary DI 00732094214154 and packaging DI 00732094212228, across the serial numbers listed in the FDA enforcement record.
Facilities can identify affected units by the model and software version above, and may contact Baxter Healthcare Corporation for further information.
The recalled product
- Product
- Brand Name: Welch Allyn, Inc. Product Name: Welch Allyn Spot Vision Screener VS100 Model/Catalog Number: VS100 Software Version: Software version 3.2.0.1 Product Description: Welch Allyn Spot Vision Screener VS100, FDA product code name: Refractometer, ophthalmic One unit pe
- Manufacturer
- Baxter Healthcare Corporation
- Affected units
- 59
Distribution
Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Same hazard · display flicker
See all →- HighMurata Vios Cardiac Monitor Model 2050 Displays Distorted and Flickering Waveforms
FDA (Devices) · 2025-01-22